Additionally, as a promising therapeutic target for metabolism, FGF21 showed the ability to enhance insulin sensitivity, lowing blood glucose and triglyceride (TG) levels, increasing brown adipocyte numbers, preserving β-cell function, inducing sustained weight loss, ameliorating hepatic steatosis, and reducing cardiovascular disease risk [12,13,14,15]. The gene discussed is FGF21; the disease is cardiovascular disorder.